Corbus Pharmaceuticals Holdings Inc (CRBP) stock has fallen -59.74% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives CRBP stock a score of 34 out of a possible 100.
That rank is influenced by a fundamental score of 3. In addition to the average rating from Wall Street analysts, CRBP stock has a mean target price of 1.84. This means analysts expect the stock to fall 33.57% over the next 12 months. CRBP's rank also includes a short-term technical score of 16. The long-term technical score for CRBP is 84.
What's Happening with CRBP Stock Today
Corbus Pharmaceuticals Holdings Inc (CRBP) stock has risen 2.79% while the S&P 500 has risen 0.69% as of 11:31 AM on Thursday, Feb 4. CRBP has risen $0.08 from the previous closing price of $2.69 on volume of 17,952,089 shares. Over the past year the S&P 500 is up 15.65% while CRBP has fallen -59.74%. CRBP lost -$1.78 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Corbus Pharmaceuticals Holdings Inc (CRBP) Stock.
